These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 20930043)

  • 1. Evaluation of role of Tigecycline among clinically significant multidrug resistant pathogens from a tertiary care hospital.
    Remash A; Rao P; Shenoy S; Baliga S; Kassim S
    F1000Res; 2024; 13():36. PubMed ID: 38872735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial evaluation and public health implications of urine as alternative therapy in clinical pediatric cases: health implication of urine therapy.
    Ogunshe AA; Fawole AO; Ajayi VA
    Pan Afr Med J; 2010 May; 5():12. PubMed ID: 21293739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007).
    Kresken M; Leitner E; Seifert H; Peters G; von Eiff C
    Eur J Clin Microbiol Infect Dis; 2009 Aug; 28(8):1007-11. PubMed ID: 19296137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antibacterial activity of doxycycline neoglycosides.
    Zhang J; Ponomareva LV; Marchillo K; Zhou M; Andes DR; Thorson JS
    J Nat Prod; 2013 Sep; 76(9):1627-36. PubMed ID: 23987662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Susceptibility Testing for Enterococci.
    Khan A; Miller WR; Axell-House D; Munita JM; Arias CA
    J Clin Microbiol; 2022 Sep; 60(9):e0084321. PubMed ID: 35695560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antibiotic resistance profiles and aminoglycoside-modifying enzyme (AME) genes in high-level aminoglycoside-resistant (HLAR) enterococci isolated from raw milk and traditional cheeses in Turkey.
    Özdemir R; Tuncer Y
    Mol Biol Rep; 2020 Mar; 47(3):1703-1712. PubMed ID: 31989429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline challenge triggers sRNA production in Salmonella enterica serovar Typhimurium.
    Yu J; Schneiders T
    BMC Microbiol; 2012 Sep; 12():195. PubMed ID: 22958399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens.
    Zarkotou O; Pournaras S; Altouvas G; Pitiriga V; Tziraki M; Mamali V; Themeli-Digalaki K; Tsakris A
    J Clin Microbiol; 2012 Nov; 50(11):3747-50. PubMed ID: 22933593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
    Garrison MW; Neumiller JJ; Setter SM
    Clin Ther; 2005 Jan; 27(1):12-22. PubMed ID: 15763603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tigecycline.
    Pankey GA
    J Antimicrob Chemother; 2005 Sep; 56(3):470-80. PubMed ID: 16040625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline activity: low resistance rates but problematic disc breakpoints revealed by a multicentre sentinel survey in the UK.
    Hope R; Mushtaq S; James D; Pllana T; Warner M; Livermore DM;
    J Antimicrob Chemother; 2010 Dec; 65(12):2602-9. PubMed ID: 20930043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method.
    Hope R; Parsons T; Mushtaq S; James D; Livermore DM
    J Antimicrob Chemother; 2007 Oct; 60(4):770-4. PubMed ID: 17704517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
    Kanj SS; Whitelaw A; Dowzicky MJ
    Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery.
    Tubau F; Liñares J; Rodríguez MD; Cercenado E; Aldea MJ; González-Romo F; Torroba L; Berdonces P; Plazas J; Aguilar L; Delgado A; García-Escribano N;
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):308-13. PubMed ID: 20022193
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.